U.S. pulls approval for Ranbaxy copies of AstraZeneca and Roche drugs

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has revoked a tentative approval for India's Ranbaxy Laboratories Ltd to make a cheap copy of AstraZeneca Plc's heartburn drug Nexium, after its Indian plants were banned over quality control issues.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news